Urological Plasma Surgery System - Gynecological Hysteroscopic Plasma Surgery system-GB/T 42061-2022/1S013485:2016 certification and GB/T 19001-2016/S09001:2015 standard certification

(This product has GB/T 42061-2022/1S013485:2016 certification and GB/T 19001-2016/S09001:2015 standard certification Export sales)

Plasma resection system – redefining precision urological surgery
▍ The world's leading 40-70°C low-temperature plasma technology
"Molecular Cold Cutting, Say Goodbye to Tissue Carbonization"

Exclusive plasma field achieves tissue molecular bond breaking at 40-70°C (traditional electrocution requires high-temperature burning at 300-400°C)

Deep thermal injury < 1mm, protecting urethral sphincter function and reducing the risk of postoperative urinary incontinence by 62% (Chinese Journal of Urology, 2023)

▍ Intelligent bipolar energy platform: accurately match the needs of the procedure
Mode of technological breakthrough clinical value
SP1 200W 300Ω High Load Penetration Cutting Large volume prostate (>80g) efficient vaporization
DES 120W Dynamic Impedance Feedback Coagulation Vascular atresia ≤ 3mm, zero tissue adhesion
Safety architecture CF type anti-shock saline perfusion No TUR syndrome • Pacemaker compatible
Three major surgeries have been revolutionized
❶ Faster recovery
90% of patients are extubated within 24 hours (traditional unipolar surgery takes 3-5 days)

Reduced average hospital stay to 1.3 days (saving hospital bed resources)

❷ Fewer complications
This system: 0% TUR syndrome | Intraoperative blood loss ↓ 50%
- Traditional unipolar: 8.2% TUR syndrome | Blood transfusions are often required
❸ More cost-effective
Electrode life: 50 units (industry average of 30 units)

No need to use expensive irrigation solution (full saline, save ¥800 per unit)

Authoritative certification and clinical endorsement
✅ ISO 13485 Medical Quality Management System